Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 April 2024 | Story Leonie Bolleurs | Photo Supplied
Eco-vehicles race
Join the UFS on 18 May 2024 from 10:00-13:00 at the Red Square Parking area for the seventh annual Kovsie ACT Eco-Vehicle Race. Come and support your favourite team to victory!

Kovsie ACT at the University of the Free State (UFS) proudly presents the seventh Kovsie Eco-Vehicle Race, set to take place at the Equitas Parking area on the Bloemfontein Campus.

According to Karen Scheepers, Assistant Director: Student Life, ten teams will be participating in this year’s race, featuring the three UFS campuses as well as the Central University of Technology. The event promise excitement like never before.

Scheepers says, besides an exciting race, spectators can look forward to a new track and viewing area. She invites the public, staff and students to come and support the competing teams as they showcase their skills on the racetrack.

Event details:

  • Date: Saturday 18 May 2024
  • Time: 10:00-13:00
  • Venue: Red Square Parking area (opposite George du Toit Building)

Breakdown of the programme:

09:00 -10:15 Performance by student artists 
10:15 -10:35 Walkthrough by judges
10:35 -10:40 Welcoming
10:40 Races commence
12:30 -13:00 Announcement of winners

13:00 -14:00 Performance by student artists

The Eco-Vehicle Race marks the culmination of a nine-month co-curricular skills programme, aimed at empowering participating students with a set of skills for the world of work. Through this programme, they are equipped with basic knowledge and abilities on sustainable energy, enabling them not only to compete in the eco-vehicle race but also to comprehend the inner workings of the vehicle. This understanding is important to the teams for when they are doing repairs during the race.

Students will be competing in three events:

• Obstacle course: Teams will be challenged by obstacles to test their control over the car.
• Smart lap: A timed lap in which the drivers take the main track for the first time.

• Endurance race: The teams need to finish as many laps as possible using the least amount of energy in 45 minutes.

The winners of the three events will each be awarded a trophy. Additionally, there will be a trophy for the best pit stop as well as a spirit cup for the team with the best energy and support from the audience.

For more information, contact Teddy Sibiya.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept